On Friday, Sana Biotechnology Inc (NASDAQ: SANA) was unchanged from the session before settling in for the closing price of $1.77. A 52-week range for SANA has been $1.26 – $10.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 25.01%. With a float of $125.15 million, this company’s outstanding shares have now reached $223.92 million.
In an organization with 194 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sana Biotechnology Inc stocks. The insider ownership of Sana Biotechnology Inc is 44.39%, while institutional ownership is 55.57%. The most recent insider transaction that took place on Feb 18 ’25, was worth 237,000. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 75,000 for $3.86, making the entire transaction worth $289,500.
Sana Biotechnology Inc (SANA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 25.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.81% during the next five years compared to -10.60% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
You can see what Sana Biotechnology Inc (SANA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.78 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.97 million. That was inferior than the volume of 6.82 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 61.69%. Additionally, its Average True Range was 0.21.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 8.44%, which indicates a significant decrease from 75.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 119.08% in the past 14 days, which was lower than the 193.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2089, while its 200-day Moving Average is $3.4615. However, in the short run, Sana Biotechnology Inc’s stock first resistance to watch stands at $1.8450. Second resistance stands at $1.9200. The third major resistance level sits at $2.0200. If the price goes on to break the first support level at $1.6700, it is likely to go to the next support level at $1.5700. Assuming the price breaks the second support level, the third support level stands at $1.4950.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
There are 225,025K outstanding shares of the company, which has a market capitalization of 398.29 million. As of now, sales total 0 K while income totals -266,760 K. Its latest quarter income was 0 K while its last quarter net income were -49,070 K.
